Gérard, Alexandre O. http://orcid.org/0000-0001-6591-6966
Merino, Diane http://orcid.org/0000-0001-7669-2339
Charbinat, Alexis
Fournier, Joseph
Destere, Alexandre
Loschi, Michael http://orcid.org/0000-0002-4460-5939
Cluzeau, Thomas http://orcid.org/0000-0002-6745-1127
Sicard, Antoine http://orcid.org/0000-0003-3427-3894
Drici, Milou-Daniel http://orcid.org/0000-0003-4121-530X
Article History
Accepted: 6 April 2023
First Online: 11 May 2023
Declarations
:
: No external funding was used in the preparation of this manuscript.
: Alexandre Olivier Gérard, Diane Merino, Alexis Charbinat, Joseph Fournier, Alexandre Destere, Michael Loschi, Thomas Cluzeau, Antoine Sicard, and Milou-Daniel Drici declare that they have no conflicts of interest that might be relevant to the contents of this manuscript. The results presented in this paper have not been published previously in whole or part.
: Ethics committee approval was not required for this observational study because the analysis was carried out on an anonymized pharmacovigilance database.
: Not applicable.
: Not applicable.
: The datasets generated during and/or analyzed during the current study are not publicly available because data are owned by UMC, which manages VigiBase®, but are available from the corresponding author on reasonable request.
: Not applicable
: Research idea and study design: AOG, DM, AS, MDD; data acquisition: AOG, DM; data analysis/interpretation: AOG, DM, AD, ML, AC, TC; statistical analysis: AOG, DM; supervision or mentorship: TC, AS, MDD.